"
Team:USTC CHINA
From 2013.igem.org
(Difference between revisions)
| Line 92: | Line 92: | ||
We hope to develop a fresh-expression transdermal vaccination. | We hope to develop a fresh-expression transdermal vaccination. | ||
<br />We hope everyone in this world could equally enjoy the benefit of medical progress.<br /> | <br />We hope everyone in this world could equally enjoy the benefit of medical progress.<br /> | ||
| - | <a href="https://2013.igem.org/Team:USTC_CHINA/Project | + | <a href="https://2013.igem.org/Team:USTC_CHINA/Project/Background">more</a> |
</div> | </div> | ||
<img class="img-right" src="https://static.igem.org/mediawiki/2013/8/8e/2013ustc-china_99.png" width="16" height="13" /></div> | <img class="img-right" src="https://static.igem.org/mediawiki/2013/8/8e/2013ustc-china_99.png" width="16" height="13" /></div> | ||
| Line 101: | Line 101: | ||
<h1>Design of Project</h1> | <h1>Design of Project</h1> | ||
<div id="pro-text"> | <div id="pro-text"> | ||
| - | With the support of <span><a href="https://2013.igem.org/Team:USTC_CHINA/Project | + | With the support of <span><a href="https://2013.igem.org/Team:USTC_CHINA/Project/Background#" target="_blank">TD-1</a></span>, a special polypeptide which can greatly facilitate macromolecule transdermal delivery through intact skin, we construct three different fuctional engineered bacillus subtilis; besides, we design a reporter system, including a kill switch, in the fouth type B.subtilis to improve usability and ensure biosafety.</div> |
<div id="ls" class="pro-col"> | <div id="ls" class="pro-col"> | ||
<img class="img-left" src="https://static.igem.org/mediawiki/2013/0/02/2013ustc-china_66.png" width="16" height="14" /> | <img class="img-left" src="https://static.igem.org/mediawiki/2013/0/02/2013ustc-china_66.png" width="16" height="14" /> | ||
| Line 108: | Line 108: | ||
As the core of our in-situ system,<br /> TD1-antigen expresser is designed<br /> and will share a great percentage of<br /> the total bacteria in our "band-aid". | As the core of our in-situ system,<br /> TD1-antigen expresser is designed<br /> and will share a great percentage of<br /> the total bacteria in our "band-aid". | ||
<br /> | <br /> | ||
| - | <a href="https://2013.igem.org/Team:USTC_CHINA/Project | + | <a href="https://2013.igem.org/Team:USTC_CHINA/Project/Design">more</a> |
</div> | </div> | ||
<img class="img-right" src="https://static.igem.org/mediawiki/2013/8/8e/2013ustc-china_99.png" width="16" height="13" /> | <img class="img-right" src="https://static.igem.org/mediawiki/2013/8/8e/2013ustc-china_99.png" width="16" height="13" /> | ||
| Line 118: | Line 118: | ||
As one kind of our adjuvant expresser,<br />TD1-LTB is used to enhance the antigenicity.<br /> For LTB has so many advantages, it's a wild using adjuvant for most of exsiting injected vaccine. | As one kind of our adjuvant expresser,<br />TD1-LTB is used to enhance the antigenicity.<br /> For LTB has so many advantages, it's a wild using adjuvant for most of exsiting injected vaccine. | ||
<br /> | <br /> | ||
| - | <a href="https://2013.igem.org/Team:USTC_CHINA/Project | + | <a href="https://2013.igem.org/Team:USTC_CHINA/Project/Design">more</a> |
</div> | </div> | ||
<img class="img-right" src="https://static.igem.org/mediawiki/2013/8/8e/2013ustc-china_99.png" width="16" height="13" /> | <img class="img-right" src="https://static.igem.org/mediawiki/2013/8/8e/2013ustc-china_99.png" width="16" height="13" /> | ||
| Line 128: | Line 128: | ||
TNFαis a chemotactic factor that recruits Langerhans Cells, antigen presenting cells beneath the skin barrier. The TNFα expresser is responsible for immigrating LC and triggering more intense immune responses. | TNFαis a chemotactic factor that recruits Langerhans Cells, antigen presenting cells beneath the skin barrier. The TNFα expresser is responsible for immigrating LC and triggering more intense immune responses. | ||
<br /> | <br /> | ||
| - | <a href="https://2013.igem.org/Team:USTC_CHINA/Project | + | <a href="https://2013.igem.org/Team:USTC_CHINA/Project/Design">more</a> |
</div> | </div> | ||
<img class="img-right" src="https://static.igem.org/mediawiki/2013/8/8e/2013ustc-china_99.png" width="16" height="13" /> | <img class="img-right" src="https://static.igem.org/mediawiki/2013/8/8e/2013ustc-china_99.png" width="16" height="13" /> | ||
| Line 138: | Line 138: | ||
Reporter notifies users whether the status of vaccine patch is all right and when they can stick the patches to arms . Further more killing switch is conveyed in them as a biosafety guard. | Reporter notifies users whether the status of vaccine patch is all right and when they can stick the patches to arms . Further more killing switch is conveyed in them as a biosafety guard. | ||
<br /> | <br /> | ||
| - | <a href="https://2013.igem.org/Team:USTC_CHINA/Project | + | <a href="https://2013.igem.org/Team:USTC_CHINA/Project/Design">more</a> |
</div> | </div> | ||
<img class="img-right" src="https://static.igem.org/mediawiki/2013/8/8e/2013ustc-china_99.png" width="16" height="13" /> | <img class="img-right" src="https://static.igem.org/mediawiki/2013/8/8e/2013ustc-china_99.png" width="16" height="13" /> | ||
| Line 160: | Line 160: | ||
<span>Protein part</span><br /> | <span>Protein part</span><br /> | ||
Before we achieve fresh expression, we use purified protein to obtain accurate data to verify our assumptions.<br /> | Before we achieve fresh expression, we use purified protein to obtain accurate data to verify our assumptions.<br /> | ||
| - | <a href="https://2013.igem.org/Team:USTC_CHINA/Project | + | <a href="https://2013.igem.org/Team:USTC_CHINA/Project/Results">more</a> |
</div> | </div> | ||
<img class="img-right" src="https://static.igem.org/mediawiki/2013/8/8e/2013ustc-china_99.png" width="16" height="13" /> | <img class="img-right" src="https://static.igem.org/mediawiki/2013/8/8e/2013ustc-china_99.png" width="16" height="13" /> | ||
Revision as of 22:30, 27 September 2013
Motivation
We hope to develop a fresh-expression transdermal vaccination.
We hope everyone in this world could equally enjoy the benefit of medical progress.
more
We hope everyone in this world could equally enjoy the benefit of medical progress.
more
Design of Project
With the support of TD-1, a special polypeptide which can greatly facilitate macromolecule transdermal delivery through intact skin, we construct three different fuctional engineered bacillus subtilis; besides, we design a reporter system, including a kill switch, in the fouth type B.subtilis to improve usability and ensure biosafety.
ANTIGEN
As the core of our in-situ system,
TD1-antigen expresser is designed
and will share a great percentage of
the total bacteria in our "band-aid".
more
As the core of our in-situ system,
TD1-antigen expresser is designed
and will share a great percentage of
the total bacteria in our "band-aid".
more
LTB
As one kind of our adjuvant expresser,
TD1-LTB is used to enhance the antigenicity.
For LTB has so many advantages, it's a wild using adjuvant for most of exsiting injected vaccine.
more
As one kind of our adjuvant expresser,
TD1-LTB is used to enhance the antigenicity.
For LTB has so many advantages, it's a wild using adjuvant for most of exsiting injected vaccine.
more
TNFα
TNFαis a chemotactic factor that recruits Langerhans Cells, antigen presenting cells beneath the skin barrier. The TNFα expresser is responsible for immigrating LC and triggering more intense immune responses.
more
TNFαis a chemotactic factor that recruits Langerhans Cells, antigen presenting cells beneath the skin barrier. The TNFα expresser is responsible for immigrating LC and triggering more intense immune responses.
more
REPORTER
Reporter notifies users whether the status of vaccine patch is all right and when they can stick the patches to arms . Further more killing switch is conveyed in them as a biosafety guard.
more
Reporter notifies users whether the status of vaccine patch is all right and when they can stick the patches to arms . Further more killing switch is conveyed in them as a biosafety guard.
more
Experimental Measurement
Molecules part
We took E.coli and the PET vector as the positive control and realized our ideas in the B.subtilis expression system based on PHT43 shuttle vector.
more
We took E.coli and the PET vector as the positive control and realized our ideas in the B.subtilis expression system based on PHT43 shuttle vector.
more
Protein part
Before we achieve fresh expression, we use purified protein to obtain accurate data to verify our assumptions.
more
Before we achieve fresh expression, we use purified protein to obtain accurate data to verify our assumptions.
more
Mice experiments
The most obvious character of our 2013USTC iGEM team is that we have not only achieved a series of molecule experiments but also tried mice experiments, which could be divided into transdermal experiments in vitro and animate mice experiments
more
The most obvious character of our 2013USTC iGEM team is that we have not only achieved a series of molecule experiments but also tried mice experiments, which could be divided into transdermal experiments in vitro and animate mice experiments
more
Thanks to the sponsors
Deutsche Bank, China
School of Life Sciences, USTC
USTCIF
School of the Gifted Young, USTC
School of physics, USTC
Teaching Affairs Office of USTC
